United States · Health Care · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-54.51%
2025 (actual)
ROA
-41.95%
2025 (actual)
Gross Margin
-
Net Margin
-
Total Assets
$262,902.00K
2025 (actual)
Net Income
-$110,290.00K
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+92.2 pt
Company
Sector average
ROA
-27.3 pt
Company
Total Assets
-39.4%
Company
Sector average (own scale)
Net Income
-0.1%
Company
Sector average (own scale)
Detailed data
USD|Thousands
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for LianBio? It covers the balance sheet, income statement, cash flow and Equlion model projections.